A Phase 1 Trial of PfSPZ Vaccine in Healthy Adults to Determine Safety, Tolerability and Efficacy Against Heterologous CHMI
Clinical trial NCT05604521 · TERMINATED
Trial details
- NCT number
- NCT05604521
- Sponsor
- Sanaria Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-06
- Primary completion
- 2023-09-05
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.